AASS-IN-1
AASS-IN-1 (Compound S-105) is an AASS (2-aminoadipic semialdehyde synthase) inhibitor with an IC50 value of 142 μM. AASS-IN-1 inhibits AASS activity by binding to the LOR domain of AASS. AASS-IN-1 holds potential for research in the field of hyperlysinemia[1].
Product Specifications
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/aass-in-1.html
Purity
98.40
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C1NC2=C(CC1)C=C(C=C2)C(N3[C@@H](CCC3)CN)=O.Cl
Molecular Formula
C15H20ClN3O2
Molecular Weight
309.79
References & Citations
[1]Leandro J, et al. Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1. Open Biol. 2022 Sep;12 (9) :220179.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402238-100 1x 100 µL
Ezrin / p81 (CPTC-Ezrin-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 